What is the expected total β‑hCG to free β‑hCG ratio in first‑trimester combined screening, and how do abnormal ratios indicate risk for trisomy 21 or trisomy 18?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 9, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

β-hCG to Free β-hCG Ratio in First Trimester Screening

The question about a "total β-hCG to free β-hCG ratio" reflects a misunderstanding of first-trimester screening methodology—laboratories measure EITHER total hCG OR free β-hCG as separate screening markers, not as a ratio between them 1.

Understanding the hCG Markers

Free β-hCG and total hCG are alternative markers used independently in first-trimester combined screening, not measured together to calculate a ratio. The choice between them depends on gestational age and screening performance 1:

Marker Selection by Gestational Age

  • Before 11 weeks: Free β-hCG is discriminatory; total hCG is not 1
  • 11-13 weeks: Free β-hCG remains more discriminatory than total hCG univariately 1
  • At 11 weeks specifically: When combined with maternal age, NT, and PAPP-A, free β-hCG performs 2-3% better detection than total hCG 1
  • At 13 weeks: Total hCG may perform slightly better (1-2% higher detection) than free β-hCG 1

Expected Marker Patterns in Aneuploidies

Trisomy 21 (Down Syndrome)

  • Free β-hCG: Elevated (significantly higher than normal controls) 2, 3
  • Total hCG: Elevated 3
  • Both markers show increased levels, making them useful screening tools 2, 3

Trisomy 18

  • Free β-hCG: Decreased (lower than normal controls) 2, 3
  • Total hCG: Decreased 3
  • The pattern is opposite to trisomy 21 2, 3

Trisomy 13

  • Free β-hCG: Decreased 3
  • Similar pattern to trisomy 18 3

Clinical Performance Data

At a 5% false-positive rate using combined screening (maternal age, NT, PAPP-A, and hCG marker) at 11-13 weeks 1:

  • Free β-hCG detection rates: 83-87% for trisomy 21
  • Total hCG detection rates: 81-84% for trisomy 21

More recent validation data shows that at a 1:100 risk cutoff with approximately 4% false-positive rate, the combined test achieves 90% detection for trisomy 21,97% for trisomy 18, and 92% for trisomy 13 4.

Important Clinical Caveats

Extremely elevated free β-hCG values (≥5 MoM) present a special consideration. Traditional risk algorithms truncate the likelihood ratio at 5 MoM, but evidence suggests that values between 5-10 MoM show increasing parabolic risk for trisomy 21 5. When free β-hCG is ≥1.5 MoM, there's also a significant relationship with chromosomal structural abnormalities 6.

The combined test integrates multiple parameters—maternal age, nuchal translucency, PAPP-A, and one form of hCG—using complex multivariate Gaussian distribution algorithms to generate patient-specific risks 7. No single marker or ratio should be interpreted in isolation.

Risk Cutoffs

  • First trimester: Typically 1:200 (equivalent to 35-year-old maternal age risk) 7
  • Alternative cutoffs of 1:150 or 1:300 are acceptable 7
  • Second trimester equivalent: 1:270 7

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.